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Electrospinning of Polycaprolactone Core-shell Nanofibers
With Anti-Cancer Drug
Sakib Iqbal, Mujibur Khan, Saheem Absar, Andrew Diamanduros, Samuel Chambers, Maxwell Friel, Quazi Nahida Sultana
Department of Mechanical Engineering, Georgia Southern University, Statesboro, GA
OBJECTIVES
 Develop a novel cancer drug delivery system using a
biocompatible core shell nanostructures for targeted delivery
and minimize side effects caused by conventional
chemotherapy method

 Processing and manufacturing of drug loaded nanofibers and
determination of structure property relationship.
 In-vitro drug release and cell viability tests of the drug
loaded nanofiber in a standard biological media

EXPERIMENTAL WORK
 Coaxial electrospinning of biocompatible, biodegradable
polymer encapsulating anticancer drug

MATERIALS AND METHOD
 Polycaprolactone (PCL) solution was prepared by dissolving 14% PCL (avg. mw 80,000)
into dimethylformamide (DMF) at 110°C
 5% 5-Fluorouracil (FU) was dissolved into DMF at 60°C

Polycaprolactone

 1% Rhodamine B and 5% 5-Fluorouracil was dissolved into DMF at 60°C
 Nanofibers of PCL encapsulating FU was electrospun at 1 ml/hr and 0.2ml/hr flow rate
respectively under 21KV
 Nanofibers of PCL encapsulating fluorescent marker Rhodamine B and 5-Fluorouracil was
electrospun at 0.9ml/hr and 0.2ml/hr flow rate respectively under 21.2KV

5-Fluorouracil

 Nanofiber were collected on a wax-paper on a flat plate collector. Nanofibers were washed
using deionized water and dried in vacuum chamber for 8hours
 20x20mm drug loaded nanofibers were put into PBS and their absorbance were recorded at
265nm using UV-Vis spectrometer to get drug release profile
 Human prostatic cancer cells were used to determine cytotoxicity of nanofibers

 Testing of nanofibers in UV-Vis Spectrometer at a controlled
temperature over a prolonged time period in a biological
media

Rhodamine B

Electrospinning with coaxial spinneret

RESULTS
SEM Images of FU loaded PCL Nanofibers

EDS Plot Showing Presence of FU in Nanofibers

Confocal Laser Microscopy of Fibers

 Different biocompatible polymer with different degradation
rate has been used to develop drug loaded nanofibers to get
variable drug release profile
 Nanofibers release drug by biodegradation of shell polymer
of coaxial structure and diffusion from the pores of shell
 Confocal laser microscopy to represent drug release from the
fiber mats
 Cytotoxicity tests were performed with human prostate
cancer cells in the department of Biology.

Cell Viability Test of Human Prostate Cancer Cells in FU Loaded PCL

Drug Release Profile of FU Loaded PCL
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FUTURE WORK
 Functionalize drug loaded nanofibers with cancer cell
targeting agents such as antibody

 In-vitro testing of cancer drug delivery device to get the
cytotoxicity and killing curve
 Testing of drug loaded nanofibers in a zebra fish containing
human prostatic cancer cell to show its efficacy
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 Conjugate nanofibers with pH sensitive polymer to obtain
capability of delivering drug only at cancer cell environment
 Develop nanospheres encapsulating drug to obtain better
permeability into human tissues and blood vessel
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Microscopic Images of Prostate Cancer Cell After Treating With FU Loaded PCL

 SEM Images of FU loaded PCL nanofibers show beaded structures which suggests
drug crystals was encapsulated within it. EDS plot shows negligible amount of drug
is attached to the surface
 Drug release profile in a biological media of FU loaded PCL nanofibers exhibit a
controlled release over a prolonged time period
 Cell viability test of human prostatic cell confirms the efficacy of FU Loaded PCL
nanofibers
 Florescence of Nanofibers in confocal microscopy demonstrate that both FU and
Rhodamine B is encapsulated within PCL nanofibers

Amount of FU loaded PCL nanofibers increasing
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